α-Melanotropin immunoreactivity in human melanoma exudate is related to necrosis

European Journal of Cancer

Volumn 34, Issue 3, 1998, Pages 424-426

  Loir, B ^a   Sales, F ^a   Deraemaecker, R ^a   Morandini, R ^a   Garcia Borron, J C ^b   Ghanem, G ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b NONE

Author keywords

melanocyte stimulating hormone; melanotropin; Malignant melanoma; Necrosis

Indexed keywords

ALPHA INTERMEDIN; CELL PROTEIN;

ARTICLE; ASPIRATION BIOPSY; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; EXUDATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; IN VITRO STUDY; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RADIOIMMUNOASSAY; TUMOR NECROSIS;

HUMANS; IMMUNOHISTOCHEMISTRY; MELANOCYTE-STIMULATING HORMONES; MELANOMA; NECROSIS; RADIOIMMUNOASSAY; TUMOR CELLS, CULTURED;

EID: 0032005595     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10016-8     Document Type: Article

References (16)

1. 1. Eberle AN. The Melanotropins: Chemistry, Physiology and Mechanism of Action. Basel, Karger, 1988.
2. 2. Bertagna X. Proopiomelanocortin-derived peptides. Endocrinol Metab Clin North Am 1994, 23, 467-485.
3. 3. Ghanem G, Verstegen J, De Rijcke S, et al. Studies on factors influencing human plasma alpha-MSH. Anticancer Res 1989, 9, 1691-1696.
4. 4. Lunec J, Pieron C, Sherbet GV, Thody AJ. Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells. Pathobiology 1990, 58, 193-197.
5. 5. Ghanem G, Loir B, Hadley M, et al. Partial characterization of IR-α-MSH peptides found in melanoma tumors. Peptides 1992, 13, 989-994.
6. 6. Liu PY, Johansson O. Immunohistochemical evidence of α-, β-and γ3-melanocyte stimulating hormone expression in cutaneous malignant melanoma of nodular type. J Dermatol Sci 1995, 10, 203-212.
7. 7. Chakraborty AK, Funasaka Y, Slominski A, et al. Production and release of pro-opiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta 1996, 1313, 130-138.
8. 8. Hunt G. Melanocyte-stimulating hormone: a regulator of human melanocyte physiology. Pathobiology 1995, 63, 12-21.
9. 9. Siegrist W, Eberle AN. Melanocortins and their implication in melanoma. Trends Endocrinol Metab 1995, 6, 115-120.
10. 10. Loir B, Bouchard B, Morandini R, et al. Immunoreactive α-melanotropin as an autocrine effector in human melanoma cells. Eur J Biochem 1997, 244, 923-930.
11. 11. Ghanem G, Lienard D, Hanson P, Lejeune F, Fruhling J. Increased serum alpha-melanocyte stimulating hormone (alpha-MSH) in human malignant melanoma. Eur J Cancer Clin Oncol 1986, 22, 535-536.
12. 12. Schwartze G, Fiedler H. Relevance of alpha-MSH plasma levels to diagnosis in human malignant melanoma. Hautarzt 1994, 45, 468-470.
13. 13. Freshney RI. Culture of Animal Cells. A Manual of Basic Technique. New York, Alan R. Liss, Inc., 1987.
14. 14. Cochran AJ, Holland GN, Saxton RE, et al. Detection and quantification of S-100 protein in ocular tissues and fluids from patients with intraocular melanoma. Br J Ophthalmol 1988, 72, 874-879.
15. 15. Cohen JJ. Apoptosis. Immunol Today 1993, 14, 126-130.
16. 16. Seidah NG, Day R, Marcinkiewicz M, Chrétien M. Mammalian paired basic amino acid convertases of prohormones and pro-proteins. In Vaudry H, Eberle AN, eds. The Melanotropic Peptides. Ann NY Acad Sci 1993, 680, 135-146.